Keiya Uriu
Keiya Uriu
1
Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
1,#,
Paúl Cárdenas
Paúl Cárdenas
2
Institute of Microbiology, Universidad San Francisco de Quito, Quito, Ecuador
2,#,
Erika Muñoz
Erika Muñoz
2
Institute of Microbiology, Universidad San Francisco de Quito, Quito, Ecuador
2,
Veronica Barragan
Veronica Barragan
2
Institute of Microbiology, Universidad San Francisco de Quito, Quito, Ecuador
2,
Yusuke Kosugi
Yusuke Kosugi
1
Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
1,
Kotaro Shirakawa
Kotaro Shirakawa
3
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3,
Akifumi Takaori-Kondo
Akifumi Takaori-Kondo
3
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3,
Kei Sato
Kei Sato
1
Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4
CREST, Japan Science and Technology Agency, Saitama, Japan
1,4,✉;
Ecuador-COVID19 Consortium, The Genotype to Phenotype Japan (G2P-Japan) Consortium
1
Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2
Institute of Microbiology, Universidad San Francisco de Quito, Quito, Ecuador
3
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4
CREST, Japan Science and Technology Agency, Saitama, Japan
#Keiya Uriu and Paúl Cárdenas contributed equally to this letter.
✉Correspondence: Kei Sato, Ph.D., The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 1088639, Japan (KeiSato@g.ecc.u-tokyo.ac.jp).
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
